Andere Sprachen Daiichi Sankyo Co., Ltd.

Aktien

A0F57T

JP3475350009

4568

Verzögert Japan Exchange Andere Börsenplätze 06:22:05 07.05.2024			% 5 Tage	% 1. Jan.
5.323 ^JPY	-3,25 %		-0,76 %	+37,47 %

05:38	Japans Nikkei steigt aufgrund der Aussicht auf Zinssenkungen der Fed und Technologieaktien	RE
30.04.	Remsons und Daiichi Infotainments gründen Joint Venture	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Japan's Nikkei climbs on Fed rate-cut outlook, tech boost	05:38
Remsons, Daiichi Infotainments Form Joint Venture	30.04.
AstraZeneca Says Enhertu Phase 3 Trial Shows 'Statistically Significant' Progression-Free Breast Cancer Survival Improvement	29.04.
AstraZeneca PLC and Daiichi Sankyo Announces ENHERTU (Fam-Trastuzumab Deruxtecan-Nxki) Improved PFS in HER2-Low and Ultralow	29.04.
AstraZeneca makes progress with Truqap and Enhertu cancer treatments	29.04.
AstraZeneca's Breast Cancer Drug Improves Progression-free Survival in Late-stage Study	29.04.
Hipgnosis Songs Fund backs new Blackstone bid	29.04.
ENHERTU® Demonstrated Statistically Significant and Clinically Meaningful Improvement in Progression-Free Survival in HR Positive, HER2 Low Metastatic Breast Cancer Following One or More Lines of Endocrine Therapy in DESTINY-Breast06 Phase 3 Trial	29.04.
Scholz sichert Pharmabranche weiter Unterstützung zu	25.04.
Daiichi Sankyo's Attributable Profit Soars 84% in Fiscal 2024	25.04.
AstraZeneca upbeat as cancer drugs underpin sales growth	25.04.
Le marché devient un peu timbré	25.04.
Daiichi Sankyo : Announces Determination of Matters Relating to Acquisition and Cancellation of Own Shares(213.5KB	25.04.
Daiichi Sankyo : FY2023 Reference Dat	25.04.
En Direct des Marchés : Hermès, Schneider, Atos, Carrefour, Casino, Sanofi, STMicro, Meta...	25.04.
Daiichi Sankyo Company, Limited Announces Dividend for the Year Ended March 31, 2024, Payable on June 18, 2024 and Provides Dividend Guidance for Second Quarter of Fiscal Ending March 31, 2025	25.04.
Daiichi Sankyo Company, Limited Provides Dividend Guidance for Full Fiscal Ending March 31, 2025	25.04.
Daiichi Sankyo Company, Limited Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2025	25.04.
Daiichi Sankyo Company, Limited announces an Equity Buyback for 55,000,000 shares, representing 2.87% for ¥200,000 million.	25.04.
Daiichi Sankyo Company, Limited authorizes a Buyback Plan.	25.04.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Daiichi Sankyo Co., Ltd.

Aktien

A0F57T

JP3475350009

4568

Andere Sprachen

Filter